NAUT vs DMAC
Comparison between Nautilus Biotechnology Inc (NAUT, Company) and DiaMedica Therapeutics Inc (DMAC, Company).
Both NAUT and DMAC are from the Healthcare sector.
5-Year PerformanceDMAC has outperformed NAUT, delivering a return of -8.2% compared to -25.9%
NAUT vs DMAC - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
NAUT vs DMAC - Historical Returns
Returns include dividend reinvestment.
NAUT vs DMAC - Annual Returns (2008 - 2026)
Returns include dividend reinvestment.
| Year | NAUT | DMAC |
|---|---|---|
| 2026 | +17.80% | -29.00% |
| 2025 | +15.38% | +44.46% |
| 2024 | -44.37% | +91.87% |
| 2023 | +76.92% | +91.89% |
| 2022 | -66.04% | -59.28% |
| 2021 | -52.91% | -62.85% |
| 2020 | N/A | +108.64% |
| 2019 | N/A | +50.15% |
| 2018 | N/A | -40.34% |
| 2017 | N/A | +127.69% |
| 2016 | N/A | +15.58% |
| 2015 | N/A | +90.00% |
| 2014 | N/A | -93.50% |
| 2013 | N/A | -33.49% |
| 2012 | N/A | -25.92% |
| 2011 | N/A | +64.60% |
| 2010 | N/A | +95.49% |
| 2009 | N/A | -58.86% |
| 2008 | N/A | -9.15% |
NAUT vs DMAC Drawdown Comparison
The maximum drawdown for NAUT was -94.19%, occurring on Sep 3, 2025. This drawdown has not yet recovered.
The maximum drawdown for DMAC was -98.16%, occurring on Dec 5, 2014. This drawdown has not yet recovered.
The current NAUT drawdown is -79.55%. The current DMAC drawdown is -87.26%.
| Rank | NAUT | DMAC |
|---|---|---|
| #1 | -94.19% Jun 10, 2021 - Sep 3, 2025 | -98.16% Aug 7, 2012 - Dec 5, 2014 |
| #2 | N/A | -73.05% Jan 4, 2008 - Jan 25, 2011 |
| #3 | N/A | -36.88% Mar 8, 2011 - Feb 27, 2012 |
| #4 | N/A | -25.49% Feb 28, 2012 - Jul 31, 2012 |
| #5 | N/A | -16.15% Jan 27, 2011 - Mar 8, 2011 |
Correlation
Correlation between NAUT and DMAC is -0.13 which considered as a very weak or no correlation - the stocks move independently of each other.
Select Stocks to Compare
More Comparisons
Compare with similar stocks